Cancer immunology and immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
| הוצא לאור ב: | Springer eBooK. |
|---|---|
| מחבר תאגידי: | |
| מחברים אחרים: | |
| פורמט: | Electronic Resource |
| שפה: | English |
| יצא לאור: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2011
|
| סדרה: | Issues in children's and families' lives
no.2 |
| נושאים: | |
| גישה מקוונת: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |